Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfer from Subutex/Suboxone to RBP-6300 in Opioid-Dependent Subjects
NCT01582347Phase 2Completed
- Sponsor
- Indivior
- Start
- Mar 2012
- Primary completion
- Nov 2012
- Countries
- 4
01
Overview
A Phase 2 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Indivior. Started Mar 2012; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01582347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01582347.